The impact of coexisting lung diseases on outcomes in patients with pathological Stage I non-small-cell lung cancer | Zendy

Hiroyuki Tao | Zendy; Hideko Onoda | Zendy; Kazunori Okabe | Zendy; Tsuneo Matsumoto | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

The impact of coexisting lung diseases on outcomes in patients with pathological Stage I non-small-cell lung cancer

Author(s) -

Hiroyuki Tao,

Hideko Onoda,

Kazunori Okabe,

Tsuneo Matsumoto

Publication year - 2018

Publication title -

interactive cardiovascular and thoracic surgery

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.546

H-Index - 56

eISSN - 1569-9293

pISSN - 1569-9285

DOI - 10.1093/icvts/ivx441

Subject(s) - medicine , lung cancer , high resolution computed tomography , stage (stratigraphy) , pathological , usual interstitial pneumonia , interstitial lung disease , lung , radiology , cancer , gastroenterology , oncology , paleontology , biology

Cigarette smoking is a well-known cause of interstitial lung disease (ILD), pulmonary emphysema and lung cancer. Coexisting pulmonary disease can affect prognosis in patients with lung cancer. The aim of this study was to determine the influence of pulmonary disease on outcomes in patients with a smoking history who had undergone surgery for pathological Stage I non-small-cell lung cancer.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research